← Leaderboards
Laurent Karl Verkoczy
Duke University
$13,792,628
Attributed
$17,554,741
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,554,741 · 5
By mechanism
R01$17,554,741 · 5
Top collaborators
- Feng Gao4 shared
- S Munir Alam2 shared
- Michael B Zwick2 shared
- John R. Perfect1 shared
- Michael Reth1 shared
Most similar at Duke University
Same institution · by research overlap
- Stuart M Levitz$22,736,478
- Charles A Specht$2,607,227
- Jennifer K. Lodge$14,326,240
- John H Sampson$43,413,436
- David C Montefiori$24,632,175
Others in their field
Top investigators on “B-Lymphocytes”
- Barton F Haynes · Duke University$400,419,833
- Lawrence Corey · Fred Hutchinson Cancer Center$83,920,398
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dan H. Barouch · Fred Hutchinson Cancer Center$66,039,430
- Dennis R. Burton · Scripps Research Institute$63,566,673
- Rafi Ahmed · Emory University$62,743,001
Research focus
B-LymphocytesNeutralizing AntibodyKnock-In MouseMutationDesignResponseImmunizationIn VivoEngineeringVaccinesHiv-1ExhibitsAntibodiesBinding SitesNovel StrategiesAntigensAffinityBaseEpitopesRegimenViralPandemic DiseaseFrequenciesAnimal Model
Grant awards (26)
Antigen recognition and activation of HIV-specific B cell antigen receptors$1,022,050
R01 · FY2025 · AI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV$912,596
R01 · FY2025 · AI
Antigen recognition and activation of HIV-specific B cell antigen receptors$1,106,519
R01 · FY2024 · AI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV$953,504
R01 · FY2024 · AI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies$945,717
R01 · FY2023 · AI · contact PI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies$1,089,767
R01 · FY2022 · AI · contact PI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$278,475
R01 · FY2022 · AI · contact PI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies$957,548
R01 · FY2021 · AI · contact PI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies$912,815
R01 · FY2020 · AI · contact PI
Dissection of polyreactivity and neutralization activity of HIV-1 Abs$612,369
R01 · FY2020 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$577,504
R01 · FY2020 · AI · contact PI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies$943,932
R01 · FY2019 · AI · contact PI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$848,532
R01 · FY2019 · AI · contact PI
Dissection of polyreactivity and neutralization activity of HIV-1 Abs$668,337
R01 · FY2019 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$816,195
R01 · FY2018 · AI · contact PI
Dissection of polyreactivity and neutralization activity of HIV-1 Abs$667,821
R01 · FY2018 · AI
Dissection of polyreactivity and neutralization activity of HIV-1 Abs$647,825
R01 · FY2017 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$286,551
R01 · FY2017 · AI · contact PI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$234,652
R01 · FY2017 · AI · contact PI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors$603,432
R01 · FY2016 · AI · contact PI
Dissection of polyreactivity and neutralization activity of HIV-1 Abs$564,366
R01 · FY2016 · AI
MPER broadly neutralizing antibody knockin mice to study anti-HIV Bcell responses$386,100
R01 · FY2014 · AI · contact PI
MPER broadly neutralizing antibody knockin mice to study anti-HIV Bcell responses$362,934
R01 · FY2013 · AI · contact PI
MPER broadly neutralizing antibody knockin mice to study anti-HIV Bcell responses$386,100
R01 · FY2012 · AI · contact PI
MPER broadly neutralizing antibody knockin mice to study anti-HIV Bcell responses$386,100
R01 · FY2011 · AI · contact PI
MPER broadly neutralizing antibody knockin mice to study anti-HIV Bcell responses$383,000
R01 · FY2010 · AI · contact PI